Dencare (Chongqing) Oral Care Co., Ltd.

SZSE:001328 Stock Report

Market Cap: CN¥5.2b

Dencare (Chongqing) Oral Care Valuation

Is 001328 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 001328 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 001328 (CN¥28.81) is trading below our estimate of fair value (CN¥44.93)

Significantly Below Fair Value: 001328 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 001328?

Key metric: As 001328 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 001328. This is calculated by dividing 001328's market cap by their current earnings.
What is 001328's PE Ratio?
PE Ratio32.7x
EarningsCN¥151.57m
Market CapCN¥5.18b

Price to Earnings Ratio vs Peers

How does 001328's PE Ratio compare to its peers?

The above table shows the PE ratio for 001328 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average26.8x
301507 Hangzhou Minsheng Healthcare
51.7xn/aCN¥4.8b
605009 Hangzhou Haoyue Personal Care
14x16.4%CN¥6.0b
300740 SYoung Group
23.2x23.7%CN¥5.0b
603896 Zhejiang Shouxiangu Pharmaceutical
18.4x19.4%CN¥4.3b
001328 Dencare (Chongqing) Oral Care
32.7x17.4%CN¥5.2b

Price-To-Earnings vs Peers: 001328 is expensive based on its Price-To-Earnings Ratio (32.7x) compared to the peer average (26.8x).

Price to Earnings Ratio vs Industry

How does 001328's PE Ratio compare vs other companies in the CN Personal Products Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
001328 32.7xIndustry Avg. 34.7xNo. of Companies5PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 001328 is good value based on its Price-To-Earnings Ratio (32.7x) compared to the CN Personal Products industry average (34.7x).

Price to Earnings Ratio vs Fair Ratio

What is 001328's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

001328 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio32.7x
Fair PE Ratio21.8x

Price-To-Earnings vs Fair Ratio: 001328 is expensive based on its Price-To-Earnings Ratio (32.7x) compared to the estimated Fair Price-To-Earnings Ratio (21.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 001328 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCN¥28.81
CN¥31.52
+9.4%
9.0%CN¥34.00CN¥27.57n/a3
Nov ’25CN¥29.37
CN¥31.52
+7.3%
9.0%CN¥34.00CN¥27.57n/a3
Oct ’25CN¥26.99
CN¥29.52
+9.4%
10.8%CN¥34.00CN¥27.00n/a3
Sep ’25CN¥24.54
CN¥28.33
+15.5%
14.8%CN¥34.00CN¥24.00n/a3
Aug ’25CN¥25.93
CN¥28.33
+9.3%
14.8%CN¥34.00CN¥24.00n/a3
Jul ’25CN¥25.99
CN¥28.33
+9.0%
14.8%CN¥34.00CN¥24.00n/a3
Jun ’25CN¥25.02
CN¥28.33
+13.2%
14.8%CN¥34.00CN¥24.00n/a3
May ’25CN¥23.59
CN¥27.33
+15.9%
17.2%CN¥34.00CN¥24.00n/a3
Apr ’25CN¥22.52
CN¥28.33
+25.8%
21.6%CN¥37.00CN¥24.00n/a3
Mar ’25CN¥22.96
CN¥28.33
+23.4%
21.6%CN¥37.00CN¥24.00n/a3

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

SYoung Group

CN¥5.0b

Engages in the research and development, production, and sale of cosmetic products in China.

300740

CN¥12.48

7D

-10.4%

1Y

-23.4%

Byhealth

CN¥21.7b

Develops and sells dietary supplements.

300146

CN¥12.90

7D

-5.4%

1Y

-28.4%

Sirio Pharma

CN¥6.2b

Operates as a contract manufacturer for dietary supplement industry worldwide.

300791

CN¥26.60

7D

-7.0%

1Y

3.3%